in the neonates there were no adverse effects on apgar scores or on the time to sustained respiration attributable to the use of atracurium . the drug concentration in the umbilical vein measured in 15 patients indicated that atracurium did not cross the placenta in amounts likely to be of clinical significance .
C0021289
neonates
C0028128
no